Shanghai Life Science & Technology
3 clinical trials · Sponsor
◉ Watch Shanghai Life Science & Technology
| Record | Firm | Date |
|---|---|---|
| Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Interstitial Lung Disease (NCT06534528) | Shanghai Life Science & Technology | 2026-10-01 |
| UC-MSC Transplantation for Left Ventricular Dysfunction After AMI (NCT03902067) | Shanghai Life Science & Technology | 2024-12-01 |
| Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF) (NCT05468502) | Shanghai Life Science & Technology | 2022-10-10 |
Track Shanghai Life Science & Technology automatically
Every clearance here is in the API, with alerts when new ones post.